Basecamp Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
8,064
-138
-2% -$16.2K 0.19% 57
2026
Q1
$987K Buy
8,202
+136
+2% +$15.7K 0.2% 55
2025
Q4
$849K Buy
+8,066
New +$757K 0.18% 57

Other funds holding MRK

Basecamp Wealth Advisors's MRK Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Merck (MRK) stake by 1.7% in Q2 2026, selling an estimated $16.2K and leaving 8,064 shares worth $1.04M. The position accounts for 0.19% of the portfolio, ranked #57.

Basecamp Wealth Advisors first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,808 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Basecamp Wealth Advisors held 8,064 shares of Merck worth $1.04M as of Q2 2026.
  • Basecamp Wealth Advisors sold 138 Merck shares in Q2 2026, an estimated $16.2K.
  • Merck made up 0.19% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #57 holding.
  • Basecamp Wealth Advisors first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,808 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.